American Shared Hospital Services reports Q1 2026 financial results: revenue up 15.9% to $7.1M, driven by 30.2% growth in direct patient services. Gamma Knife andAmerican Shared Hospital Services reports Q1 2026 financial results: revenue up 15.9% to $7.1M, driven by 30.2% growth in direct patient services. Gamma Knife and

American Shared Hospital Services Reports 15.9% Revenue Growth in Q1 2026, Driven by Direct Patient Services Expansion

2026/05/14 19:18
3분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 [email protected]으로 연락주시기 바랍니다

American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery equipment and advanced radiation therapy services, reported financial results for the first quarter ended March 31, 2026, showing a 15.9% increase in total revenue to $7.1 million compared to $6.1 million in the same period last year. The growth was primarily fueled by a 30.2% rise in direct patient services revenue, which reached $4.1 million, driven by higher patient volumes at its Rhode Island radiation therapy centers and its facility in Puebla, Mexico.

Gross margin improved 36.7% to $1.3 million, or 18.2% of revenue, up from $0.9 million, or 15.4%, in the prior year period. Adjusted EBITDA increased 18.4% to $1.1 million, reflecting better operational efficiency. The company also reported a reduction in operating loss to $(0.9) million from $(1.3) million, though net loss remained flat at $(0.6) million.

Operationally, Gamma Knife procedures grew 10.1% year-over-year to 229, while proton beam radiation therapy (PBRT) treatments increased 20.7% to 1,003. The company noted that volumes are continuing to trend higher into the second quarter. Leasing revenue remained stable at $3.0 million, as prior Gamma Knife contract expirations were partially offset by improved volumes at upgraded sites.

Craig Tagawa, Interim CEO, stated, “We are encouraged by our performance in the first quarter of 2026, which reflects continued momentum in our direct patient care services segment and improved utilization across our treatment centers.” Executive Chairman Ray Stachowiak added, “Growth across our LINAC and proton therapy platforms reflects increasing demand for advanced radiation therapy services, and we remain focused on further increasing utilization, improving reimbursement profiles, and driving sustained revenue expansion.”

CFO Scott Frech highlighted the company’s focus on capital structure optimization, noting, “As utilization continues to ramp up across our network, we expect to drive further margin expansion and increased profitability. We are also actively focused on enhancing our capital structure to support the next phase of growth.”

The company ended the quarter with $5.2 million in cash, up from $3.7 million at year-end 2025, driven by improved operating performance. Long-term debt decreased to $16.8 million from $17.3 million. Management continues discussions with its lender regarding a potential extension of certain debt obligations.

The results underscore AMS’s strategic shift toward direct patient care, which now accounts for a larger share of revenue. As the company ramps up utilization at its newer facilities, investors will watch for continued margin expansion and a path to profitability. A conference call to discuss the results was scheduled for 12:00 PM ET on May 14, 2026, with a replay available through May 21, 2026, at 1-855-669-9658, access code 6753554, or on the company’s website at www.ashs.com.

For more information, visit www.ashs.com.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by PRISM Mediawire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is American Shared Hospital Services Reports 15.9% Revenue Growth in Q1 2026, Driven by Direct Patient Services Expansion.

The post American Shared Hospital Services Reports 15.9% Revenue Growth in Q1 2026, Driven by Direct Patient Services Expansion appeared first on citybuzz.

시장 기회
RISE 로고
RISE 가격(RISE)
$0.002916
$0.002916$0.002916
-2.57%
USD
RISE (RISE) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, [email protected]으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

No Chart Skills? Still Profit

No Chart Skills? Still ProfitNo Chart Skills? Still Profit

Copy top traders in 3s with auto trading!